Related Experiment Videos
Neuropilin-2 expression affects the increased vascularization and is a prognostic factor in osteosarcoma
A Handa1, T Tokunaga, T Tsuchida
1Department of Pathology, Tokai University School of Medicine, Bohseidai, Isehara-shi, Kanagawa 259-1193, Japan.
International Journal of Oncology
|July 13, 2000
Summary
Neuropilins (NRPs) amplify vascular endothelial growth factor (VEGF) in osteosarcoma. NRP2 expression in bone tumors correlates with increased vascularity and poorer patient prognosis, highlighting a potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Pathology
Background:
- Osteosarcoma is a malignant bone tumor known for its high vascularity.
- Neuropilins (NRPs) are receptors for vascular endothelial growth factor (VEGF) and are expressed in human tumor cells.
Purpose of the Study:
- To investigate the role of NRP mRNA expression in osteosarcoma.
- To determine the correlation between NRP expression, tumor vascularity, and patient prognosis.
Main Methods:
- Analysis of NRP mRNA expression in 30 osteosarcoma samples.
- Statistical analysis including Mann-Whitney U test and Wilcoxon's test to compare vascularity and prognosis based on NRP2 expression.
Main Results:
- NRP2 mRNA expression was detected in 24 out of 30 osteosarcomas.
- Osteosarcomas with NRP2 expression exhibited significantly increased vascularity (P<0.0014).
- NRP2 expression was associated with a significantly poorer prognosis (P=0.016).
Conclusions:
- NRPs may function as VEGF-amplifiers in osteosarcoma, acting in a paracrine or autocrine manner.
- NRP2 expression cooperates with VEGF to promote angiogenesis and tumor growth in osteosarcoma.
- NRP2 represents a potential biomarker for predicting prognosis and a therapeutic target in osteosarcoma.